| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |